FDA 483 - Kolmask Co., Ltd. - September 27, 2024
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
Kolmask Co., Ltd. in Namdong-gu Incheon, South Korea, was inspected by the FDA, resulting in four observations. The inspection revealed deficiencies in cleaning and maintenance procedures, lack of validation for microbial test methods, issues with representative sampling of drug products, and incomplete master production and control records for water usage. These findings indicate potential concerns regarding the quality and control of OTC drug product manufacturing.
ID · 909248da-72d9-4656-84f7-f7a431ea16cf